Ian investigates the impact drug use has on individuals and populations. Focusing on the social, health and political issues related to drug and alcohol use.

He writes a regular column for The Independent - https://www.independent.co.uk/author/ian-hamilton-0, provides opinion pieces for the British Medical Journal as well as publishing academic papers.

Prior to becoming an academic Ian worked as a mental health nurse working with people who had a severe mental health problem and used drugs or alcohol problematically. He also has experience of working with rough sleepers and people who are homeless.

Experience

  • 2004–present
    Associate professor, University of York

Publications

  • 2022
    The UK tinkers around the edges of drug policy but it still needs national reform, BMJ
  • 2021
    Alcohol related deaths are on the rise, but we reamin a nation indenial., BMJ
  • 2021
    Those with the least have suffered the most during the covid-19 pandemic, BMJ
  • 2020
    Loosening regulations on controlled drugs during the covid-19 pandemic., BMJ
  • 2020
    Even in a pandemic, young people are still exploited by county line drug gangs., BMJ
  • 2020
    Is alcohol really 'essential' during covid-19 ?, BMJ
  • 2020
    Covid-19 - are we rationing who we care about ?, BMJ
  • 2020
    Focusing on GHB ignores the more common involvement of alcohol in sexual assault., BMJ
  • 2020
    They talk, we die - the continuing paralyses of UK drug policy, BMJ
  • 2020
    Will prejudice be a barrier to understanding the potential of psychedelics in treating depression?, BMJ
  • 2020
    What will covid-19 mean for the illegal drug market and people dependent on it ? , BMJ
  • 2019
    Dry January is no match for the growing harms of alcohol consumption, BMJ
  • 2019
    The gaps in our understanding of cannabis dependence, BMJ
  • 2019
    Reclassifying pregabalin and gabapentin only moves the problem onto other drugs, BMJ
  • 2019
    Cannabis and Psychosis: Are We any Closer to Understanding the Relationship?, Current Psychiatry Reports
  • 2019
    The inequality of deaths from alcohol., BMJ
  • 2019
    New guidelines for prescribing medicinal cannabis—another dashed hope for patients., BMJ
  • 2019
    Prescription drugs are no cure for deprivation., BMJ
  • 2018
    A 10 year strategy for mental health research which ignores drug use., Advances in Dual Diagnosis
  • 2018
    Decisions about medicinal cannabis should be made by the health department., BMJ
  • 2018
    A painful lesson: are we repeating previous mistakes in pain management?, The Lancet
  • 2018
    Language alone cannot reduce the stigma that people who use drugs experience. , BMJ
  • 2018
    Rising numbers of older and female cannabis users seeking treatment in England and Wales., Drugs: Education, prevention and policy.
  • 2018
    Are middle class drug users really to blame for the rise in violent crime?, BMJ
  • 2018
    Are nurses ready to manage patient expectations of cannabis-based products ?, Nursing Times
  • 2018
    Licensing process for medicinal cannabis will be neither swift nor equitable., Nursing Times
  • 2017
    Healthcare professionals need more guidance to reduce the risk of cannabis related health problems, BMJ
  • 2017
    Cannabis, psychosis and schizophrenia: unravelling a complex interaction, Journal of Addiction
  • 2016
    Guidance is needed on synthetic cannabinoid receptor agonists and cannabis., BMJ
  • 2016
    Cannabis matters? Treatment responses to increasing cannabis presentations in addiction services in England., Drugs Education Prevention and Policy
  • 2016
    Could campaigns like Dry January do more harm than good ?, BMJ
  • 2016
    The need for health warnings about cannabis and psychosis., The Lancet Psychiatry
  • 2016
    Rebranding schizophrenia is unlikely to reduce stigma., BMJ
  • 2016
    A national prescription drug line could help assess the non-medical use of prescription drugs., BMJ
  • 2015
    Psychotropic induced sexual dysfunction for people with a dual diagnosis., Advances in Dual Diagnosis
  • 2015
    The impact of assertive outreach teams on hospital admissions for psychosis, Journal of Psychiatric and Mental Health Nursiing
  • 2015
    Cannabis psychosis, gender matters., Advances in Dual Diagnosis
  • 2014
    The 10 most important debates surrounding Dual Diagnosis, Advances in Dual Diagnosis
  • 2014
    The emerging cannabis treatment population, Drugs and Alcohol Today
  • 2013
    Effect of reclassification of cannabis on hospital admissions for cannabis psychosis: A time series analysis., International Journal of Drug Policy
  • 2013
    Drug interactions and dual diagnosis, Advances in Dual Diagnosis

Professional Memberships

  • Nursing and Midwifery Council
  • Society for the study of addiction
  • Expert Royal College of Nursing

Contact Ian for

  • General
  • Media request
  • Speaking request
  • Consulting / Advising